Gyrodyne , LLC (NASDAQ:GYRO) Sees Significant Increase in Short Interest

Gyrodyne , LLC (NASDAQ:GYRO) was the target of a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 203 shares, an increase of 407.5% from the January 15th total of 40 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 1,544 shares, the short-interest ratio is presently 0.1 days. Based on an average trading volume of 1,544 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the shares of the stock are sold short.

Institutional Trading of Gyrodyne

A number of institutional investors and hedge funds have recently made changes to their positions in GYRO. Bulldog Investors LLP purchased a new stake in Gyrodyne in the 3rd quarter worth $601,000. Teton Advisors LLC acquired a new stake in shares of Gyrodyne in the third quarter valued at about $177,000. Susquehanna International Group LLP purchased a new stake in shares of Gyrodyne during the third quarter worth about $142,000. Finally, Advisory Services Network LLC acquired a new position in shares of Gyrodyne during the 3rd quarter worth about $77,000. 71.36% of the stock is currently owned by hedge funds and other institutional investors.

Gyrodyne Price Performance

GYRO stock opened at $8.80 on Wednesday. Gyrodyne has a 52-week low of $6.80 and a 52-week high of $12.00. The company’s 50-day simple moving average is $9.06 and its 200-day simple moving average is $9.67.

About Gyrodyne

Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.

The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.